Skip to main content

Illumina Wins Reddot 2021 Award: Genomic Sequencing System NextSeq 1000/2000

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

--News Direct--

Illumina's NextSeq 1000/2000 sequencing systems are based on a technology that leverages light to decipher the genome. The instruments are used, among other things, to determine the genetic profile of the SARS-CoV-2 virus and its variants. The housing is made of high-grade aluminium and reflects the technological quality and precision of the instruments. The most striking design feature is the circumferential light bar that uses colour changes to make the working status clearly visible from all directions. The digital interface takes up the product aesthetics and creates a seamless user experience.

Statement by the Jury

The high design quality of the NextSeq 1000/2000 sequencing system manifests in elegant contours and the exciting use of light.

View additional multimedia and more ESG storytelling from Illumina on 3blmedia.com

View source version on newsdirect.com: https://newsdirect.com/news/illumina-wins-reddot-2021-award-genomic-sequencing-system-nextseq-1000-2000-155872204

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  263.56
-2.76 (-1.04%)
AAPL  309.94
+1.12 (0.36%)
AMD  493.95
+26.44 (5.66%)
BAC  52.08
+0.28 (0.53%)
GOOG  382.31
+2.93 (0.77%)
META  609.72
-0.54 (-0.09%)
MSFT  414.90
-3.67 (-0.88%)
NVDA  213.63
-1.70 (-0.79%)
ORCL  191.37
-0.71 (-0.37%)
TSLA  432.05
+6.04 (1.42%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.